Ulf Sundin

• Sundet, Mads; Sundin, Ulf Gunnar; Godø, Aasmund; Sydnes, Kristian; Valland, Haldor & Sexton, Joseph [Show all 10 contributors for this article] (2024). Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients. European Journal of Trauma and Emergency Surgery. ISSN 1863-9933. doi: 10.1007/s00068-024-02532-9.
• Sundlisæter, Nina Beate Paulshus; Sundin, Ulf Gunnar; Aga, Anna-Birgitte; Sexton, Joseph; Hammer, Hilde Berner & Uhlig, Till [Show all 9 contributors for this article] (2022). Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study. RMD Open. ISSN 2056-5933. 8(1), p. 1–6. doi: 10.1136/rmdopen-2021-002013. Full text in Research Archive Show summary

  Objective To investigate limiting factors of American College of Rheumatology (ACR)/EULAR Boolean remission in rheumatoid arthritis (RA), and compare patients who fulfil the criteria to patients who only partly fulfil the criteria, with respect to imaging inflammation and biologic disease modifying anti-rheumatic drug (DMARD) usage. Methods Patients with DMARD-naïve RA were treated according to current recommendations in the the ARCTIC trial (Aiming for Remission in rheumatoid arthritis: a randomised trial examining the benefit of ultrasound in a Clinical TIght Control regimen). Limiting factors of reaching ACR/EULAR Boolean remission at 2 years were assessed. Imaging inflammation (ultrasound and MRI) in patients in remission was compared with patients failing to fulfil different components of the criteria. The OR of biologic therapy was calculated using logistic regression. Results Of 203 patients, 112 (55%) reached ACR/EULAR Boolean remission; 49 (24%) fulfilled three of four criteria. The main limiting factors were patient global assessment (PGA) (59%) and tender joints (22%). Imaging inflammation was not significantly different for patients in remission and patients not fulfilling the criteria due to elevated PGA and/or tender joints, but higher odds of using biologics (OR 3.63, 95% CI 1.73 to 7.61) were observed. Conclusions PGA and tender joints were the factors most often limiting achievement of ACR/EULAR Boolean remission. The level of imaging inflammation was not elevated in these patients compared with patients in remission, but the odds of using biologic DMARDs were higher. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

• Sundin, Ulf Gunnar; Sundlisæter, Nina Beate Paulshus; Aga, Anna-Birgitte; Sexton, Joseph; Nordberg, Lena Kristine Bugge & Hammer, Hilde Berner [Show all 10 contributors for this article] (2021). Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-To-Target strategy. RMD Open. ISSN 2056-5933. 7:e001525(1), p. 1–11. doi: 10.1136/rmdopen-2020-001525. Full text in Research Archive
• Sundin, Ulf Gunnar; Aga, Anna-Birgitte; Skare, Øivind; Nordberg, Lena Kristine Bugge; Uhlig, Till & Hammer, Hilde Berner [Show all 10 contributors for this article] (2020). Conventional versus ultrasound treat to target: No difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis. Rheumatology. ISSN 1462-0324. 59(9), p. 2550–2555. doi: 10.1093/rheumatology/kez674. Full text in Research Archive
• Sundin, Ulf Gunnar; Østergaard, Mikkel; Glinatsi, Daniel; Aga, Anna-Birgitte; Hørslev-Petersen, Kim & Hetland, Merete L. [Show all 13 contributors for this article] (2019). Validity and responsiveness of combined inflammation and combined joint damage scores based on the OMERACT rheumatoid arthritis MRI scoring system (RAMRIS). Journal of Rheumatology. ISSN 0315-162X. 46(9), p. 1222–1227. doi: 10.3899/jrheum.181064.

View all works in Cristin

• Melokhina, Valeriia; Paulshus Sundlisæter, Nina; Sexton, Joseph; Sundin, Ulf Gunnar; Aga, Anna-Birgitte & Kjørholt, Kaja Eriksrud [Show all 10 contributors for this article] (2023). Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: Data from the ARCTIC study. Annals of the Rheumatic Diseases. ISSN 0003-4967. doi: 10.1136/ard-2023-224950.
• Kjeken, Ingvild & Sundin, Ulf Gunnar (2022). Management of carpal tunnel syndrome in primary care. Rheumatology. ISSN 1462-0324. 62(2), p. 495–496. doi: 10.1093/rheumatology/keac396.

View all works in Cristin